Improving Overactive Bladder Treatment Access and Adherence Through Personalized Behavioral Modifications and Mobile Technology-Based Interventions
Improving Overactive Bladder Treatment Access and Adherence Through Personalized Behavioral Modifications and Mobile Technology-Based Interventions
批准号:
10682476
负责人:
Ekene Enemchukwu
金额:
$19.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-15 至 2027-07-31
关键词:
AdherenceAffectAmericanAwardBehavior TherapyCaringChronicClinicalDataDevelopmentDiagnosisDiseaseEvidence based interventionEvidence based treatmentFemaleFundingGoalsHealthHealth PersonnelHealth Services AccessibilityImprove AccessIncreased frequency of micturitionInternationalInterventionInterviewKnowledgeLeadLow incomeMethodsMinority GroupsOutcomeOveractive BladderPatient EducationPatientsPerceptionPharmacotherapyPilot ProjectsPopulationPositioning AttributeProceduresProcessProviderPublishingQuality of lifeRandomizedResearchResearch PersonnelRiskRoleStigmatizationStructureSymptomsSyndromeTestingTreatment EfficacyUnderserved PopulationUrinary IncontinenceVeteransVulnerable PopulationsWomanWomen&aposs Groupbarrier to carecare seekingcostcost effectivedesignefficacy trialempowermentethnic diversityevidence baseexpectationfuture implementationhealth care deliveryimprovedinnovationmHealthmicturition urgencyminimally invasivemobile applicationmobile computingmultidisciplinarypatient engagementpatient expectationpatient orientedpilot testpilot trialprovider-level barriersracial diversitysatisfactionside effectsocial health determinantstherapy adherencetherapy durationtherapy outcometooltreatment adherencetreatment as usualtreatment planningurinaryusability
中文摘要
项目摘要/摘要
获得机会较少,对OAB慢性病、预期结果、成本和患者教育不足
潜在的副作用导致患者对治疗和次优治疗时间的不切实际的看法,
特别是在弱势群体中。因此,这导致治疗的可获得性、依从性和
不适当的治疗。我的长期目标是发展成为一名独立资助的调查员和国际
领导者,他将率先采取干预措施,改善OAB治疗的可及性、依从性和结果,从而
减轻这一慢性病的负担。这项K23提案的总体目标是设计一个
创新的、利益相关者知情的战略,纳入了治疗障碍(如社会决定因素
健康),并改善患者获得治疗选择和治疗依从性的机会。中心假设是
由于缺乏渠道和次优的提供者对患者的OAB而未满足患者的期望和知识
医疗服务的提供是坚持治疗的障碍。这一核心假说将在两个月内得到检验
具体目标:1.评估适用于多元化、多文化人群的用户界面移动健康工具
并确定障碍和促进者,从以下方面获得、遵守治疗和参与
多个关键利益相关者。2.开展试点研究,评估使用手机的可用性和可行性
健康工具,在不同的人群中提高OAB知识、参与度和治疗计划的遵守情况
患有OAB的女性。拟议研究的理由是,它的完成预计将提供一个强有力的
以证据为基础的框架,以继续开发和今后执行成本效益高的方案,
循证干预,以改善OAB治疗的可及性和依从性。综合这些结果是
通过让我提交竞争性的R01申请,预计会产生重要的积极影响
提出一项改善治疗可获得性、依从性和OAB结果的随机对照疗效试验
在该奖项的第四个年头。
英文摘要
PROJECT SUMMARY/ABSTRACT
Poor access and insufficient patient education regarding OAB chronicity, expected outcomes, costs, and
potential side effects lead to unrealistic patient perceptions about therapy and suboptimal therapy duration,
particularly in vulnerable populations. This thus leads to poor treatment access, adherence, and
undertreatment. My long-term goal is to develop as an independently funded investigator and international
leader who will pioneer interventions that improve OAB therapy access, adherence and outcomes, thereby
reducing the burden of this chronic condition. The overall objective for this K23 proposal is to design an
innovative, stakeholder-informed strategy that incorporates barriers to treatment (such as social determinants
of health) and improves patient access to therapy options and therapy adherence. The central hypothesis is
that unmet patient expectations and knowledge due to lack of access and suboptimal provider-to-patient OAB
healthcare delivery are a barrier to treatment adherence. This central hypothesis will be tested pursuing two
specific aims: 1. Evaluate an adapted UI mobile health tool for use in a diverse, multicultural population of
women with OAB and identify barriers and facilitators to access, treatment adherence and engagement from
multiple key stakeholders. 2. Conduct a pilot study to evaluate the usability and feasibility of using a mobile
health tool to improve OAB knowledge, engagement and treatment plan adherence in a diverse group of
women with OAB. The rationale for the proposed research is that its completion is expected to provide a strong
evidence-based framework for the continued development and future implementation of cost-effective,
evidence-based interventions to improve OAB therapy access and adherence. Combined these results are
expected to have an important positive impact by positioning me to submit a competitive R01 application
proposing a randomized controlled efficacy trial for improving therapy access, adherence, and OAB outcomes
during the fourth year of this award.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving Overactive Bladder Treatment Access and Adherence Through Personalized Behavioral Modifications and Mobile Technology-Based Interventions
-
批准号:10525607
-
项目类别:
-
资助金额:$19.53万
-
财政年份:2022
-
负责人:Ekene Enemchukwu
-
依托单位:
海外基金